Angus Derek C, Seymour Christopher W, Coopersmith Craig M, Deutschman Clifford S, Klompas Michael, Levy Mitchell M, Martin Gregory S, Osborn Tiffany M, Rhee Chanu, Watson R Scott
1Department of Critical Care Medicine, The Clinical Research, Investigation, and Systems Modeling of Acute illness (CRISMA) Center, University of Pittsburgh School of Medicine, Pittsburgh, PA.2Department of Surgery, Emory University School of Medicine, Atlanta, GA.3Department of Pediatrics, Hofstra-North Shore-LIJ School of Medicine, Cohen Children's Medical Center, New Hyde Park, NY.4Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA.5Department of Medicine, Brigham and Women's Hospital, Boston, MA.6Division of Pulmonary/Critical Care Medicine, Alpert Medical School at Brown University, Providence, RI.7Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Critical Care, Emory University School of Medicine, Atlanta, GA.8Departments of Surgery and Emergency Medicine, Washington University School of Medicine, St. Louis, MO.9Department of Pediatrics, Pediatric Critical Care Medicine, University of Washington; Center for Child Health Behavior and Development, Seattle Children's Research Institute, Seattle, WA.
Crit Care Med. 2016 Mar;44(3):e113-21. doi: 10.1097/CCM.0000000000001730.
Although sepsis was described more than 2,000 years ago, and clinicians still struggle to define it, there is no "gold standard," and multiple competing approaches and terms exist. Challenges include the ever-changing knowledge base that informs our understanding of sepsis, competing views on which aspects of any potential definition are most important, and the tendency of most potential criteria to be distributed in at-risk populations in such a way as to hinder separation into discrete sets of patients. We propose that the development and evaluation of any definition or diagnostic criteria should follow four steps: 1) define the epistemologic underpinning, 2) agree on all relevant terms used to frame the exercise, 3) state the intended purpose for any proposed set of criteria, and 4) adopt a scientific approach to inform on their usefulness with regard to the intended purpose. Usefulness can be measured across six domains: 1) reliability (stability of criteria during retesting, between raters, over time, and across settings), 2) content validity (similar to face validity), 3) construct validity (whether criteria measure what they purport to measure), 4) criterion validity (how new criteria fare compared to standards), 5) measurement burden (cost, safety, and complexity), and 6) timeliness (whether criteria are available concurrent with care decisions). The relative importance of these domains of usefulness depends on the intended purpose, of which there are four broad categories: 1) clinical care, 2) research, 3) surveillance, and 4) quality improvement and audit. This proposed methodologic framework is intended to aid understanding of the strengths and weaknesses of different approaches, provide a mechanism for explaining differences in epidemiologic estimates generated by different approaches, and guide the development of future definitions and diagnostic criteria.
尽管脓毒症在2000多年前就已被描述,但临床医生仍在努力对其进行定义,目前尚无“金标准”,且存在多种相互竞争的方法和术语。挑战包括不断变化的知识基础(它影响着我们对脓毒症的理解)、对于任何潜在定义的哪些方面最为重要存在相互竞争的观点,以及大多数潜在标准在高危人群中的分布方式往往会阻碍将患者分为不同的离散组。我们建议,任何定义或诊断标准的制定和评估应遵循四个步骤:1)定义认识论基础;2)就用于构建该工作的所有相关术语达成一致;3)阐明任何一套拟议标准的预期用途;4)采用科学方法来了解其对于预期用途的有用性。有用性可通过六个领域来衡量:1)可靠性(复测期间、评估者之间、随时间推移以及不同环境下标准的稳定性);2)内容效度(类似于表面效度);3)结构效度(标准是否衡量了其声称要衡量的内容);4)标准效度(新标准与标准相比的表现);5)测量负担(成本、安全性和复杂性);6)及时性(标准是否能在护理决策时同时获得)。这些有用性领域的相对重要性取决于预期用途,预期用途大致可分为四类:1)临床护理;2)研究;3)监测;4)质量改进与审核。这一拟议的方法框架旨在帮助理解不同方法的优缺点,提供一种机制来解释不同方法所产生的流行病学估计值的差异,并指导未来定义和诊断标准的制定。